Tak Yin Owen Tsang

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 458 citations

Pharmacy, Infectious Diseases, Pharmacology +11

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Susan Olender, Katherine K Perez, Alan S. Go et al. · Clinical Infectious Diseases · 2020 · 171 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study

Harry L.A. Janssen, Young-Suk Lim, Pietro Lampertico et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 13 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Epstein-Barr virus-associated smooth muscle tumor in patients with acquired immunodeficiency syndrome.

Ka‐Hing Wong, K. Chan, Shui Shan Lee et al. · PubMed · 2007 · 11 citations

Life Sciences, Oncology, Pathology +14